首站-论文投稿智能助手
典型文献
A novel viewpoint in glaucoma therapeutics: enriched environment
文献摘要:
Glaucoma is one of the world's most frequent visual impairment causes and leads to selective damage to retinal ganglion cells and their axons. Despite glaucoma's most accepted risk factor is increased intraocular pressure (IOP), the mechanisms behind the disease have not been fully elucidated. To date, IOP lowering remains the gold standard; however, glaucoma patients may still lose vision regardless of effective IOP management. Therefore, the exclusive IOP control apparently is not enough to stop the disease progression, and developing new resources to protect the retina and optic nerve against glaucoma is a goal of vast clinical importance. Besides pharmacological treatments, environmental conditions have been shown to prevent neurodegeneration in the central nervous system. In this review, we discuss current concepts on key pathogenic mechanisms involved in glaucoma, the effect of enriched environment on these mechanisms in different experimental models, as well as recent evidence supporting the preventive and therapeutic effect of enriched environment exposure against experimental glaucomatous damage. Finally, we postulate that stimulating vision may become a non-invasive and rehabilitative therapy that could be eventually translated to the human disease, preventing glaucoma-induced terrible sequelae resulting in permanent visual disability.
文献关键词:
作者姓名:
María F.González Fleitas;Damián Dorfman;Ruth E.Rosenstein
作者机构:
Laboratory of Retinal Neurochemistry and Experimental Ophthalmology,Department of Human Biochemistry,School of Medicine/CEFyBO,University of Buenos Aires/CONICET,Buenos Aires,Argentina
引用格式:
[1]María F.González Fleitas;Damián Dorfman;Ruth E.Rosenstein-.A novel viewpoint in glaucoma therapeutics: enriched environment)[J].中国神经再生研究(英文版),2022(07):1431-1439
A类:
glaucomatous,rehabilitative
B类:
novel,viewpoint,therapeutics,enriched,Glaucoma,one,world,most,frequent,visual,impairment,causes,leads,selective,damage,retinal,ganglion,cells,their,axons,Despite,accepted,risk,increased,intraocular,pressure,IOP,mechanisms,behind,disease,have,not,been,fully,elucidated,To,lowering,remains,gold,standard,however,patients,may,still,lose,vision,regardless,effective,management,Therefore,exclusive,control,apparently,enough,stop,progression,developing,new,resources,protect,optic,nerve,against,goal,vast,clinical,importance,Besides,pharmacological,treatments,environmental,conditions,shown,neurodegeneration,central,nervous,system,In,this,review,discuss,current,concepts,key,pathogenic,involved,these,different,experimental,models,well,recent,evidence,supporting,preventive,exposure,Finally,postulate,that,stimulating,become,invasive,therapy,could,eventually,translated,human,preventing,induced,terrible,sequelae,resulting,permanent,disability
AB值:
0.640823
相似文献
Spirulina platensis aqueous extracts ameliorate colonic mucosal damage and modulate gut microbiota disorder in mice with ulcerative colitis by inhibiting inflammation and oxidative stress
Jian WANG;Liqian SU;Lun ZHANG;Jiali ZENG;Qingru CHEN;Rui DENG;Ziyan WANG;Weidong KUANG;Xiaobao JIN;Shuiqing GUI;Yinghua XU;Xuemei LU-Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances,School of Life Science and Biopharmaceutics,Guangdong Pharmaceutical University,Guangzhou 510006,China;School of Pharmacy,Guangdong Pharmaceutical University,Guangzhou 510006,China;Intensive Care Unit,Shenzhen Second People's Hospital,the First Affiliated Hospital of Shenzhen University,Shenzhen 518031,China;Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products,National Institutes for Food and Drug Control,Beijing 102629,China
Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway
Yi-kuan Wu;Zheng-nan Ren;Sheng-long Zhu;Yun-zhou Wu;Gang Wang;Hao Zhang;Wei Chen;Zhao He;Xian-long Ye;Qi-xiao Zhai-State Key Laboratory of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Medicine,Jiangnan University,Wuxi 214122,China;College of Life Science,Northeast Agricultural University,Harbin 150038,China;National Engineering Research Center for Functional Food,Jiangnan University,Wuxi 214122,China;Shandong Key Laboratory of Endocrinology and Lipid Metabolism,Jinan 250021,China;School of Medicine,Shandong University,Jinan 250012,China;Ganjiang Chinese Medicine Innovation Center,Nanchang 330000,China
Plasma metabolomics in the perioperative period of defect repair in patients with pulmonary arterial hypertension associated with congenital heart disease
Yang-yang He;Yi Yan;Ji-wang Chen;Sheng Liu;Lu Hua;Xin Jiang;Xi-qi Xu;Dan Lu;Zhi-cheng Jing;Fu-xia Yan;Zhi-yan Han-State Key Laboratory of Cardiovascular Disease and FuWai Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037,China;School of Pharmacy,Henan University,Kaifeng 475004,China;Institute for Cardiovascular Prevention(IPEK),Ludwig-Maximilians-University Munich,Munich,Germany;DZHK(German Centre for Cardiovascular Research),Partner Site Munich Heart Alliance,Munich,Germany;Section of Pulmonary,Critical Care Medicine,Sleep and Allergy,Department of Medicine,University of Illinois at Chicago,Chicago,IL,USA;Department of Surgery,FuWai Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037,China;Department of Internal Medicine,FuWai Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037,China;State Key Laboratory of Complex,Severe,and Rare Diseases,and Department of Cardiology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100730,China;Department of Anesthesiology,FuWai Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037,China
NFAT inhibitor 11R-VIVIT ameliorates mouse renal fibrosis after ischemia-reperfusion-induced acute kidney injury
Zhi-yong Xie;Wei Dong;Li Zhang;Meng-jie Wang;Zhen-meng Xiao;Yu-hua Zhang;Wan-xin Shi;Ying Huang;Yan Yang;Cui-li Li;Lei Fu;Xing-chen Zhao;Rui-zhao Li;Zhi-lian Li;Yuan-han Chen;Zhi-ming Ye;Shuang-xin Liu;Zheng Dong;Xin-ling Liang-The Second School of Clinical Medicine,Southern Medical University,Guangzhou 510515,China;Division of Nephrology,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China;School of Medicine,South China University of Technology,Guangzhou 510006,China;Department of Cellular Biology and Anatomy,Medical College of Georgia at Augusta University,Augusta,GA,USA;Department of Medical Research,Charlie Norwood Veterans Affairs Medical Center,Augusta,GA,USA
Therapeutic potential of colchicine in cardiovascular medicine:a pharmacological review
Fan-shun Zhang;Qing-ze He;Chengxue Helena Qin;Peter J.Little;Jian-ping Weng;Suo-wen Xu-Institute of Endocrine and Metabolic Diseases,The First Affiliated Hospital of USTC,Division of Life Science and Medicine,University of Science and Technology of China,Hefei 230001,China;Faculty of Pharmacy and Pharmaceutical Sciences,Monash Institute of Pharmaceutical Sciences,Monash University(Parkville Campus),381 Royal Parade,Parkville 3052 VIC,Australia;Sunshine Coast Health Institute,University of the Sunshine Coast,Birtinya 4575 QLD,Australia;School of Pharmacy,The University of Queensland,Woolloongabba 4102 QLD,Australia;Biomedical Sciences and Health Laboratory of Anhui Province,University of Science&Technology of China,Hefei 230027,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。